HLA-B27 and its subtypes in world populations

Current Opinion in Rheumatology
M A Khan

Abstract

Twenty-five years ago, HLA-B27 was recognized as a new HLA specificity. It is present throughout Eurasia but is virtually absent among the genetically unmixed native populations of South America, the Bantus and Sans (Bushmen) of equatorial and southern Africa, and the aborigines of Australia. B27 is a serologically determined specificity that encompasses nine different allotypes (subtypes), B*2701 to B*2709. Ankylosing spondylitis or related spondyloarthropathies thus far have been documented in individuals with any of the following five subtypes: B*2701, B*2702, B*2704, B*2705, or B*2707.

Citations

Jan 20, 1998·Arthritis and Rheumatism·J BraunJ Sieper
Jul 21, 2000·Arthritis and Rheumatism·P EkmanK Granfors
Feb 1, 1997·Arthritis and Rheumatism·H AwadiaD Charron
Aug 6, 2009·Rheumatology International·Mohamed Montacer KchirSondes Makni
Sep 24, 2009·Rheumatology International·Xiang LiuQun-Feng Yao
Jan 3, 2012·Rheumatology International·Mario SlausMislav Cavka
Dec 28, 2012·Rheumatology International·Sang-Hoon LeeHyung-In Yang
Jan 31, 2012·Zeitschrift für Rheumatologie·D PoddubnyyJ Sieper
Mar 7, 2009·Modern Rheumatology·Mohammad Ali NazariniaZahra Habibagahi
Aug 1, 1997·International Journal of Cardiology·N K MehraB K Sharma
Jun 1, 2005·The Medical Clinics of North America·Gail S KerrE Nigel Harris
Nov 15, 2001·Joint, Bone, Spine : Revue Du Rhumatisme·E J Ball, M A Khan
Jul 26, 2000·Current Opinion in Rheumatology·M A Khan
Sep 14, 2001·Current Opinion in Rheumatology·J D ReveilleM A Khan
Apr 1, 1997·Inflammatory Bowel Diseases·S G MeuwissenB A Dijkmans
Feb 1, 1997·Tissue Antigens·S Gonzalez-RocesC López-Larrea
Oct 2, 1998·Tissue Antigens·T WagnerG Lanzer
Dec 8, 1998·Australian and New Zealand Journal of Ophthalmology·J R Smith, D J Coster
Jan 1, 1997·Annals of the Rheumatic Diseases·J TuokkoA Toivanen
May 4, 1999·Annals of the Rheumatic Diseases·R A Roberts-Thomson, P J Roberts-Thomson
Mar 24, 2000·The British Journal of Ophthalmology·M Huhtinen, A Karma
Nov 11, 2003·American Journal of Respiratory and Critical Care Medicine·Anthony W O'Regan, Jeffrey S Berman
Jul 31, 2012·BMC Ophthalmology·Alexandra WexlerTor B Elsås
Nov 30, 2013·Arthritis Research & Therapy·Rebecca L RobertsSimon M Stebbings
Sep 27, 2005·Pediatric Research·Jane G Schaller
Jan 1, 1996·Clinical Rheumatology·U KangaT E Feltkamp
Feb 19, 2014·Journal of Autoimmunity·Siba P Raychaudhuri, Atul Deodhar
Sep 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Julia R GogBryan T Grenfell
Sep 24, 2009·Current Rheumatology Reports·Ignazio OlivieriMuhammad A Khan
Aug 5, 2010·Current Rheumatology Reports·Muhammad Asim Khan
Aug 13, 2011·Current Rheumatology Reports·Monika Ronneberger, Georg Schett
Jan 23, 2016·Clinical Rheumatology·Wilson Bautista-MolanoDésirée van der Heijde
Oct 16, 2015·International Journal of Rheumatic Diseases·Abhijeet Danve, James O'Dell
Oct 23, 2012·Rheumatic Diseases Clinics of North America·Carmen StolwijkJohn D Reveille

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.